Mitesco (MITI) Current Deferred Revenue (2011 - 2026)
Mitesco (MITI) reported Current Deferred Revenue of $10000.0 for Q1 2026, little changed on a QoQ basis from $10000.0 in Q4 2025.
Mitesco (MITI) has 8 years of Current Deferred Revenue data on file, last reported at $10000.0 in Q1 2026.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10000.0 (changed N/A YoY) and the FY2025 annual result came in at $10000.0, changed N/A from the prior year.
- Current Deferred Revenue steadied at $10000.0 in Q1 2026 per MITI's latest filing, from $10000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $10000.0 in Q3 2025 and bottomed at $10000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mitesco | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 1,000.00 |
| Sep 30, 2015 | 245,555.00 |
| Jun 30, 2015 | 271,807.00 |
| Mar 31, 2015 | 298,059.00 |
| Dec 31, 2014 | 324,169.00 |
| Sep 30, 2014 | 281,883.00 |
| Dec 31, 2013 | 315,850.00 |
| Sep 30, 2013 | 335,100.00 |
| Jun 30, 2013 | 386,783.00 |
| Mar 31, 2013 | 3,378.00 |
| Dec 31, 2012 | 5,907.00 |
| Jun 30, 2012 | 15,192.00 |
| Mar 31, 2012 | 10,134.00 |
| Dec 31, 2011 | 10,134.00 |